Search Results

Displaying Results 1-1 of 1 "'PBYI'"

Jan 22, 2026, 05:00 ET New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand

available in Thailand by independent pharmaceutical company, Specialised Therapeutics (ST), under exclusive license from Puma Biotechnology, Inc. (Nasdaq:  PBYI).ST Chief Executive Officer, Mr Carlo Montagner, said NERLYNX is the first therapy the company is launching in Thailand and is in response to

More news about: Specialised Therapeutics


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.